Catalyst Wire Dossier Catalyst Wire Dossier

PG324 ophthalmic solution

PG324 · Alcon Research
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PG324 ophthalmic solution, covering 2019-05-01 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction [Phase 3]

See pricing